Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.
Anodyne Nanotech has raised $12.6M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
Anodyne Nanotech's investors include Big Pi Ventures, Bantam Group, Velocity Partners, Evercurious VC, Relativity Healthcare Partners.
Anodyne Nanotech is headquartered in Boston, United States.
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.
Anodyne Nanotech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anodyne Nanotech — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/anodyne-nanotech. Accessed August 14, 2026.
VCBacked. (2026). Anodyne Nanotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/anodyne-nanotech
{{cite web |title=Anodyne Nanotech — Funding & Investors |url=https://www.vcbacked.co/company/anodyne-nanotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated